About

Transforming fragmented evidence into clear decisions.

Hubert Rose Consulting is a health strategy and evidence advisory firm helping biotech teams move from evidence complexity to decision clarity. 

We combine advanced epidemiology training with more than 20 years of pharmaceutical industry experience. The firm provides senior-level expertise across HEOR, RWE, market access, and evidence generation, with experience spanning clinical development, launch readiness, payer evidence strategy, and lifecycle planning. Hubert Rose can lead a defined strategy engagement, advise an internal team, or work alongside research, analytics, market access, and communications vendors. We help ensure that execution is anchored to the evidence decision the organization needs to support.

Human in the loop

Proprietary E2D toolkit used to support structured evidence review. Final judgments are made by senior experts

Stakeholder-first, always

Evidence is only sufficient if it can withstand the decision standards of the stakeholder who needs to act on it.

Honest gaps

We name what the evidence does and doesn't resolve, plainly.

Adaptive Methodology

Our E2D toolkit is updated as evidence standards, stakeholder expectations, and market access requirements evolve.

How we support teams

We help teams assess what evidence exists, where the strategy is vulnerable, what evidence is still needed, and which actions should be prioritized to support the asset value, payer readiness, launch planning, and lifecycle decisions. Our work is grounded in a proprietary E2D Toolkit, a structured internal framework used to evaluate evidence packages against stakeholder needs, decision risks, and asset strategy requirements.

Start a conversation